Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma | ||
| dc.conicet.organizacion | Aarhus University Hospital. Department of Hematology | |
| dc.conicet.organizacion | University Aarhus | |
| dc.conicet.organizacion | Aarhus University Hospital. Institute of Pathology | |
| dc.conicet.organizacion | Aarhus University Hospital. Institute of Pathology | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i) | |
| dc.conicet.organizacion | Odense University Hospital. Department of Pathology | |
| dc.conicet.organizacion | University Aarhus | |
| dc.conicet.organizacion | University Aarhus | |
| dc.conicet.organizacion | Aarhus University Hospital. Department of Hematology | |
| dc.contributor.author | Kamper, Peter | |
| dc.contributor.author | Lugvigsen, Maja | |
| dc.contributor.author | Bendix, Knud | |
| dc.contributor.author | Hamilton Dutoit, Stephen | |
| dc.contributor.author | Rabinovich, Gabriel Adrián | |
| dc.contributor.author | Boe Møller, Michael | |
| dc.contributor.author | Nyengaard, Jens | |
| dc.contributor.author | Honoré, Bent | |
| dc.contributor.author | d'Amore, Franceso | |
| dc.date.issued | 2011-06 | |
| dc.description.abstract | Considerable effort has been spent identifying prognostic biomarkers in classic Hodgkin lymphoma (cHL). The aim of our study was to search for possible prognostic parameters in advanced-stage cHL using a proteomics-based strategy. A total of 14 cHL pretreatment tissue samples from younger, advanced-stage patients were included. Patients were grouped according to treatment response. Proteins that were differentially expressed between the groups were analyzed using 2D-PAGE and identified by liquid chromatography mass spectrometry. Selected proteins were validated using Western blot analysis. One of the differentially expressed proteins, the carbohydrate-binding protein galectin-1 (Gal-1), was further analyzed using immunohistochemistry HC and its expression was correlated with clinicopathologic and outcome parameters in 143 advanced-stage cHL cases. At the univariate level, high Gal-1 expression in the tumor microenvironment was correlated with poor event-free survival (P = .02). Among younger (≤ 61 years) patients, high Gal-1 was correlated with poorer overall and event-free survival (both P = .007). In this patient group and at the multivariate level, high Gal-1 expression retained a significant predictive impact on event-free survival. Therefore, in addition to its functional role in cHL-induced immunosuppression, Gal-1 is also associated with an adverse clinical outcome in this disease. | es |
| dc.description.fil | Fil: Kamper, Peter. Aarhus University Hospital. Department of Hematology; Dinamarca | |
| dc.description.fil | Fil: Lugvigsen, Maja. University Aarhus; Dinamarca | |
| dc.description.fil | Fil: Bendix, Knud. Aarhus University Hospital. Institute of Pathology; Dinamarca | |
| dc.description.fil | Fil: Hamilton Dutoit, Stephen. Aarhus University Hospital. Institute of Pathology; Dinamarca | |
| dc.description.fil | Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina | |
| dc.description.fil | Fil: Boe Møller, Michael. Odense University Hospital. Department of Pathology; Dinamarca | |
| dc.description.fil | Fil: Nyengaard, Jens. University Aarhus; Dinamarca | |
| dc.description.fil | Fil: Honoré, Bent. University Aarhus; Dinamarca | |
| dc.description.fil | Fil: d'Amore, Franceso. Aarhus University Hospital. Department of Hematology; Dinamarca | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Kamper, Peter; Lugvigsen, Maja; Bendix, Knud; Hamilton Dutoit, Stephen; Rabinovich, Gabriel Adrián; et al.; Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma; American Society Of Hematology; Blood, The Journal Of The American Society Of Hematology - Print; 117; 24; 6-2011; 6638-6649 | es |
| dc.identifier.issn | 0006-4971 | es |
| dc.identifier.uri | http://hdl.handle.net/11336/10664 | |
| dc.journal.ciudad | Chicago | es |
| dc.journal.number | 24 | es |
| dc.journal.pagination | 6638-6649 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Blood, The Journal Of The American Society Of Hematology - Print | es |
| dc.journal.volume | 117 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Society Of Hematology | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://www.bloodjournal.org/content/117/24/6638 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1182/blood-2010-12-327346 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | es |
| dc.subject | Hodgkin Lymphoma | es |
| dc.subject | Biomarker | es |
| dc.subject | Galectin-1 | es |
| dc.subject | Proteomics | es |
| dc.subject.classification | Patología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.14288.pdf
- Tamaño:
- 1.46 MB
- Formato:
- Adobe Portable Document Format